Product NewsDrug discovery > Clinical Development ISA Pharmaceuticals Presents Novel Data at the European Cancer Congress 2013: Strong Synergies Between Cancer Vaccine ISA101 and Chemotherapy
Product NewsDrug discovery > Clinical Development ISA Pharmaceuticals Initiates Phase I/II Clinical Trial of ISA101 in Patients with Anal Intraepithelial Neoplasia (AIN)
Product NewsDrug discovery > Target Discovery Cobra Biologics and Vaccibody Sign Agreement to Manufacture DNA Vaccine
